Chlamydia pneumoniae infection suppresses Staphylococcus enterotoxin B-induced proliferation associated with down-expression of CD25 in lymphocytes

Canadian Journal of Microbiology

Volumn 56, Issue 4, 2010, Pages 289-294

  Hirai, Itaru ^a   Utsumi, Maki ^a   Yamaguchi, Hiroyuki ^a,b   Yamamoto, Yoshimasa ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CD25; Chlamydia pneumoniae; Infection; Lymphocytes

Indexed keywords

CELL NUMBER; CHLAMYDIA PNEUMONIAE; CHRONIC INFLAMMATORY DISEASE; ENTEROTOXIN; HUMAN PERIPHERAL BLOOD; IMMUNE FUNCTION; IMMUNE MODULATION; IMMUNOLOGICAL STIMULATION; S. AUREUS; STAPHYLOCOCCUS AUREUS;

CELL CULTURE;

INTERLEUKIN 2 RECEPTOR ALPHA; STAPHYLOCOCCUS ENTEROTOXIN B; VERY LATE ACTIVATION ANTIGEN 4;

BACTERIAL DISEASE; BLOOD; CELL ORGANELLE; GENE EXPRESSION; IMMUNE RESPONSE; PATHOGENICITY;

ARTICLE; CELL COUNT; CHLAMYDIAL PNEUMONIA; CONTROLLED STUDY; DOWN REGULATION; HUMAN; IN VITRO STUDY; LYMPHOCYTE; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL PROLIFERATION; CELL SEPARATION; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DOWN-REGULATION; ENTEROTOXINS; HUMANS; INTEGRIN ALPHA4BETA1; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTES; T-LYMPHOCYTES;

CHLAMYDOPHILA PNEUMONIAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 77951660845     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/W10-018     Document Type: Article

References (29)

1. Airenne, S., Surcel, H.M., Alakärppä, H., Laitinen, K., Paavonen, J., Saikku, P., and Laurila, A. 1999. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67(3): 1445-1449. PMID:10024593.
2. Balin, B.J., Gérard, H.C., Arking, E.J., Appelt, D.M., Branigan, P.J., Abrams, J.T., et al. 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. (Berl.), 187(1): 23-42. doi:10.1007/s004300050071. PMID:9749980.
3. Belland, R.J., Ouellette, S.P., Gieffers, J., and Byrne, G.I. 2004. Chlamydia pneumoniae and atherosclerosis. Cell. Microbiol. 6(2): 117-127. doi:10.1046/j.1462-5822.2003.00352.x. PMID:14706098.
4. Campbell, L.A., and Kuo, C.C. 2004. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2(1): 23-32. doi:10.1038/nrmicro796. PMID:15035006.
5. Collison, L.W., Workman, C.J., Kuo, T.T., Boyd, K., Wang, Y., Vignali, K.M., et al. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature (Lond.), 450(7169): 566-569. doi:10.1038/nature06306. PMID:18033300.
6. Fryer, R.H., Schwobe, E.P., Woods, M.L., and Rodgers, G.M. 1997. Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J. Investig. Med. 45(4): 168-174. PMID:9154297.
7. Garín, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollón, E., Wait, R., and Lechler, R.I. 2007. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood, 109(5): 2058-2065. doi:10.1182/blood-2006- 04-016451. PMID:17110462.
8. Gaydos, C.A., Summersgill, J.T., Sahney, N.N., Ramirez, J.A., and Quinn, T.C. 1996. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64(5): 1614-1620. PMID:8613369.
9. Grayston, J.T., Campbell, L.A., Kuo, C.C., Mordhorst, C.H., Saikku, P., Thom, D.H., and Wang, S.P. 1990. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161(4): 618-625. PMID:2181028.
10. Haranaga, S., Yamaguchi, H., Friedman, H., Izumi, S., and Yamamoto, Y. 2001. Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect. Immun. 69(12): 7753-7759. doi:10.1128/IAI.69.12.7753-7759.2001. PMID:11705957.
11. Ikejima, H., Friedman, H., and Yamamoto, Y. 2006. Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease. J. Med. Microbiol. 55(7): 947-952. doi:10.1099/jmm.0. 46348-0. PMID:16772424.
12. Jackson, L.A., Campbell, L.A., Kuo, C.C., Rodriguez, D.I., Lee, A., and Grayston, J.T. 1997. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J. Infect. Dis. 176(1): 292-295. doi:10.1086/517270. PMID:9207386.
13. Kaperonis, E.A., Liapis, C.D., Kakisis, J.D., Dimitroulis, D., and Papavassiliou, V.G. 2006. Inflammation and atherosclerosis. Eur. J. Vasc. Endovasc. Surg. 31(4): 386-393. doi:10.1016/j.ejvs.2005.11.001. PMID:16359887.
14. Kim, H.P., Imbert, J., and Leonard, W.J. 2006. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 17(5): 349-366. doi:10.1016/j.cytogfr.2006.07.003. PMID:16911870. (Pubitemid 44604346)
15. Kuo, C.C., Gown, A.M., Benditt, E.P., and Grayston, J.T. 1993. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler. Thromb. 13(10): 1501-1504. PMID:7691166.
16. Liu, C., and Waters, D.D. 2005. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials. Prog. Cardiovasc. Dis. 47(4): 230-239. doi:10.1016/j.pcad.2005.01.001. PMID:15991152.
17. Petersson, K., Forsberg, G., and Walse, B. 2004. Interplay between superantigens and immunoreceptors. Scand. J. Immunol. 59(4): 345-355. doi:10.1111/j.0300-9475.2004.01404.x. PMID:15049778.
18. Quinn, T.C., and Gaydos, C.A. 1999. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am. Heart J. 138(5 Suppl.): S507-S511. doi:10.1016/S0002-8703(99)70287-5. PMID:10539860.
19. Roblin, P.M., Dumornay, W., and Hammerschlag, M.R. 1992. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30(8): 1968-1971. PMID:1500500.
20. Saikku, P., Leinonen, M., Mattila, K., Ekman, M.R., Nieminen, M.S., Mäkelä, P.H., et al. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 2(8618): 983-986. doi:10.1016/S0140-6736(88)90741-6. PMID:2902492.
21. Sessa, R., Di Pietro, M., Schiavoni, G., Macone, A., Maras, B., Fontana, M., et al. 2009. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-a. Int. J. Immunopathol. Pharmacol. 22(3): 659-668. PMID:19822082.
22. Shevach, E.M. 2009. Mechanisms of foxp3+ T regulatory cellmediated suppression. Immunity, 30(5): 636-645. doi:10.1016/j.immuni.2009.04.010. PMID:19464986.
23. Sriram, S., Stratton, C.W., Yao, S., Tharp, A., Ding, L., Bannan, J.D., and Mitchell, W.M. 1999. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 46(1): 6-14. doi:10.1002/1531- 8249(199907)46:1〈6::AIDANA4〉3.0.CO;2-M. PMID:10401775.
24. Stratton, C.W., and Sriram, S. 2003. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect. 5(13): 1249-1253. doi:10.1016/j.micinf.2003.09.004. PMID:14623021.
25. Stratton, C.W., and Wheldon, D.B. 2006. Multiple sclerosis: an infectious syndrome involving Chlamydophila pneumoniae. Trends Microbiol. 14(11): 474-479. doi:10.1016/j.tim.2006.09.002. PMID:16996738.
26. Takano, R., Yamaguchi, H., Sugimoto, S., Nakamura, S., Friedman, H., and Yamamoto, Y. 2005. Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae. Curr. Microbiol. 50(3): 160-166. PMID:15883875.
27. Yamaguchi, H., Haranaga, S., Friedman, H., Moor, J.A., Muffly, K.E., and Yamamoto, Y. 2002a. A Chlamydia pneumoniae infection model using established human lymphocyte cell lines. FEMS Microbiol. Lett. 216(2): 229-234. doi:10.1111/j.1574-6968.2002.tb11440.x. PMID:12435507.
28. Yamaguchi, H., Haranaga, S., Widen, R., Friedman, H., and Yamamoto, Y. 2002b. Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect. Immun. 70(5): 2392-2398. doi:10.1128/IAI.70.5.2392-2398. 2002. PMID:11953375.
29. Yamaguchi, H., Matsuo, J., Sugimoto, S., Utsumi, M., and Yamamoto, Y. 2008. Inhibition of lymphocyte CD3 expression by Chlamydophila pneumoniae infection. Microb. Pathog. 45(4): 290-296. doi:10.1016/j.micpath.2008.06.005. PMID:18674609.